March, 24

InSysBio announces its participation in Quantitative Systems Pharmacology Conference 2022 (QSPC2022) which is to be held on April 20-22, 2022, Leiden, The Netherlands. InSysBio team is going to present its QSP tools at the Booth and 15 posters in frames of the Conference, namely:

• "Stimulation of erythropoiesis with ESA or blood donation: QSP model" by Alexander Stepanov, Galina Lebedeva
• "fIVE Database is a repository of in vitro data and estimates of kinetic parameters for systems modeling" by Alexander Stepanov, Veronika Musatova, Anna Victorenko, Ekaterina Goryacheva, Nail Gizzatkulov, Oleg Demin
• "CYTOCON DB as a tool to store and analyze in vivo human concentrations of cells and molecules" by Ekaterina Mogilevskaia, Vladislav Leonov, Elita Gerasimuk, Nikolay Pervushin, Nail Gizzatkulov, Oleg Demin
• "QSP model that describes neurofilament L protein dynamics in Alzheimer’s disease" by Polina Pchelintseva
• "Application of Immune Response Template (IRT) to the COVID19 QSP platform prototype development" by Veronika Musatova, Oleg Demin, Anna Viktorenko, Anastasia Ivanova
• "Prediction of pharmacokinetics and optimal dose for a bispecific antibody against CD40 and PD1" by Alexandra Diakonova, Oleg Demin Jr, Dmitry Shchelokov, Oleg Demin 
• "Collection of methodological findings for QSP model development" by Oleg Demin, Maria Mironovich, Julia Sergienko
• "Method to describe multiple effects of regulatory molecules on cell dynamics process in QSP models of immune response" by Oleg Demin, Sergey Smirnov, Galina Lebedeva
• "Exploration of structural differences between mechanism-based PK/PD and QSP models" by Oleg Demin
• "Comparison Of Different Approaches To Generate Virtual Patient Populations Of Different Sizes For QSP Model Of Erythropoiesis" by Galina Kolesova, Oleg Demin
• "Exploration of potential efficacy of tau-targeting immunotherapy and simulation of combination of immunotherapies targeting tau and amyloid using QSP approach" by Tatiana Karelina, Polina Pchelintseva, Oleg Demin
• "Confidence Intervals by Constrained Optimization – a Single Algorithm for Identifiability and Predictability Analysis in Systems Biology" by Ivan Borosov, Evgeny Metelkin
• "Dynamic and reproducible reports for QSP modeling in R and Julia: working examples" by Evgeny Metelkin, Ivan Borisov
• "QSP Modeling of Thrombopoiesis and Essential Thrombocythemia Treatment" by Svetlana Rubina¹, Artem Ivanov², Galina Lebedeva¹

Affiliation: (1) InSysBio, Moscow, Russia, (2) Lomonosov Moscow State University, Moscow, Russia

• "QSP model of human granulopoiesis and neutrophil homeostasis under growth factor, stem-cell mobilizing and cytotoxic therapies" by Galina Lebedeva, Alexander Stepanov

See our latest posters: InSysBio team posters

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

Share